Regulation of Gene Expression by PML

PML 对基因表达的调控

基本信息

  • 批准号:
    7246574
  • 负责人:
  • 金额:
    $ 28.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The promyelocytic leukemia PML gene is consistently disrupted by the nonrandom chromosomal translocation t(15; 17) in acute promyelocytic leukemia. PML is a protein with multiple functions involves in regulation of apoptosis, cell cycle progression, gene expression, genome stability, and cellular senescence. How PML involves in such diverse multiple regulatory functions remains unknown. When fused downstream of the GAL4-DNA binding domain, PML acts as a transcriptional repressor by recruiting histone deacetylases. PML also represses transcription by interacting with different transcription factors including Sp 1, Nur77, and NF-kappaB and disrupt their binding to the DNA target sites. PML activates fos-mediated AP-1 transactivation. PML also mediates transactivation by recruiting coactivator CBP has been reported by several groups, strongly supporting a role of PML in transcription activation. PML interacts with p53, forms a PML/p53/CBP complex and upregulates p53 mediated transcription. The objectives of this proposal are to understand the mechanisms of gene expression regulated by PML. Based on the results accomplished in the preliminary studies, our main hypothesis is that PML regulates transcription by (1) interaction and sequestration of transcription factors; (2) recruits CBP/HDACs to the target promoters to achieve transcriptional activation and repression. The following three specific aims will be pursued to support the hypothesis: 1. We will study the mechanism and functional significance of transcriptional repression by PML. Our hypothesis predicts that PML interacts and sequesters transcription factors and limiting their accessibility to the DNA binding sites. We will test the hypothesis by CHIP assay, double color immunofluorescence staining, co-purification of PML and its associated proteins in the nuclear matrix, and to study how PML regulates the availability of Spl during G1/S cell cycle transition. 2. We will study the functional significance of different PML isoforms in mediating expression of target genes. We hypothesize that alternative splicing of the primary PML transcript produces various isoforms with different C-terminals regulating different target genes. We will study the transcriptional regulatory functions of different PML isoforms; study the expression pattern, cellular distribution. 3. We will identify and characterize the PML target genes mediated through HDACs and CBP. Our hypothesis predicts that PML recruits corepressors HDACs and coactivator CBP to the target promoters and represses/activates transcription. We will identify PML target genes by construction and screening of a chromatin immunoprecipitated DNA library, identify the PML target genes by the genome-wide location technology, and to characterize the PML target genes. Finally we will investigate whether these PML target genes are deregulated in acute promyelocytic leukemia.
描述(由申请人提供):急性早幼粒细胞白血病中的非随机染色体易位t(15; 17)持续破坏早幼粒细胞白血病PML基因。PML是一种具有多种功能的蛋白质,涉及细胞凋亡、细胞周期进程、基因表达、基因组稳定性和细胞衰老的调节。PML如何参与如此多样的多重调节功能仍不清楚。当融合在GAL 4-DNA结合结构域的下游时,PML通过招募组蛋白脱乙酰酶来充当转录抑制因子。PML还通过与不同的转录因子(包括Sp 1、Nur 77和NF-κ B)相互作用抑制转录,并破坏它们与DNA靶位点的结合。PML激活fos介导的AP-1反式激活。PML还通过募集共激活因子CBP介导转录激活,几个研究小组已报告,强烈支持PML在转录激活中的作用。PML与p53相互作用,形成PML/p53/CBP复合物并上调p53介导的转录。该提案的目的是了解PML调控基因表达的机制。基于初步研究的结果,我们的主要假设是PML通过(1)转录因子的相互作用和隔离来调节转录;(2)将CBP/HDAC募集到靶启动子以实现转录激活和抑制。以下三个具体目标将被追求,以支持这一假设:1。我们将研究PML抑制转录的机制和功能意义。我们的假设预测,PML相互作用和隔离转录因子,并限制其访问的DNA结合位点。我们将通过CHIP法、免疫荧光双染色、共纯化PML及其相关蛋白来验证这一假设,并研究PML在G1/S细胞周期转换过程中对Spl的调节作用。2.我们将研究不同PML亚型在介导靶基因表达中的功能意义。我们假设,选择性剪接的主要PML转录产生不同的C-末端调节不同的靶基因的各种亚型。我们将研究不同PML亚型的转录调控功能,研究其表达模式、细胞分布。3.我们将鉴定和表征通过HDAC和CBP介导的PML靶基因。我们的假设预测,PML招募辅抑制因子HDAC和辅激活因子CBP的目标启动子和抑制/激活转录。我们将通过构建和筛选染色质免疫沉淀DNA文库来鉴定PML靶基因,通过全基因组定位技术来鉴定PML靶基因,并对PML靶基因进行表征。最后,我们将研究这些PML靶基因是否在急性早幼粒细胞白血病中失调。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUN-SANG CHANG其他文献

KUN-SANG CHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUN-SANG CHANG', 18)}}的其他基金

Regulation of Gene Expression by PML
PML 对基因表达的调控
  • 批准号:
    6942449
  • 财政年份:
    2003
  • 资助金额:
    $ 28.67万
  • 项目类别:
Regulation of Gene Expression by PML
PML 对基因表达的调控
  • 批准号:
    6807029
  • 财政年份:
    2003
  • 资助金额:
    $ 28.67万
  • 项目类别:
Regulation of Gene Expression by PML
PML 对基因表达的调控
  • 批准号:
    7118005
  • 财政年份:
    2003
  • 资助金额:
    $ 28.67万
  • 项目类别:
Regulation of Gene Expression by PML
PML 对基因表达的调控
  • 批准号:
    6731288
  • 财政年份:
    2003
  • 资助金额:
    $ 28.67万
  • 项目类别:
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA
急性早幼粒细胞白血病的分子病理学
  • 批准号:
    6192152
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:
A Role for PML in Genome Stability and DNA Damage Response
PML 在基因组稳定性和 DNA 损伤反应中的作用
  • 批准号:
    8215849
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA
急性早幼粒细胞白血病的分子病理学
  • 批准号:
    2330801
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA
急性早幼粒细胞白血病的分子病理学
  • 批准号:
    2871764
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:
A Role for PML in Genome Stability and DNA Damage Response
PML 在基因组稳定性和 DNA 损伤反应中的作用
  • 批准号:
    7373528
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:
MOLECULAR PATHOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA
急性早幼粒细胞白血病的分子病理学
  • 批准号:
    3200074
  • 财政年份:
    1992
  • 资助金额:
    $ 28.67万
  • 项目类别:

相似海外基金

Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
  • 批准号:
    488788
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
    Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
  • 批准号:
    10638347
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
  • 批准号:
    10717440
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
  • 批准号:
    10577186
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
  • 批准号:
    10749474
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
  • 批准号:
    10673458
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
  • 批准号:
    2884151
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
    Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
  • 批准号:
    10660668
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
  • 批准号:
    2239056
  • 财政年份:
    2023
  • 资助金额:
    $ 28.67万
  • 项目类别:
    Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
  • 批准号:
    468851650
  • 财政年份:
    2022
  • 资助金额:
    $ 28.67万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了